The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia

Amit Mahipal, Mark Weiss

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia'. Together they form a unique fingerprint.